Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts
収録刊行物
-
- Journal of Controlled Release
-
Journal of Controlled Release 205 144-154, 2015-05
Elsevier BV